399 related articles for article (PubMed ID: 9677321)
1. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
Sharom FJ; Lu P; Liu R; Yu X
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
[TBL] [Abstract][Full Text] [Related]
3. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
Sharom FJ; Yu X; DiDiodato G; Chu JW
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores.
Sharom FJ; DiDiodato G; Yu X; Ashbourne KJ
J Biol Chem; 1995 Apr; 270(17):10334-41. PubMed ID: 7730340
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
6. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Borgnia MJ; Eytan GD; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
[TBL] [Abstract][Full Text] [Related]
7. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1998 May; 254(1):189-93. PubMed ID: 9652413
[TBL] [Abstract][Full Text] [Related]
8. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Shapiro AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):130-7. PubMed ID: 9432000
[TBL] [Abstract][Full Text] [Related]
9. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
10. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
12. Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles.
Mazzanti R; Fantappié O; Kamimoto Y; Gatmaitan Z; Gentilini P; Arias IM
Hepatology; 1994 Jul; 20(1 Pt 1):170-6. PubMed ID: 7912687
[TBL] [Abstract][Full Text] [Related]
13. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
14. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
Romsicki Y; Sharom FJ
Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
[TBL] [Abstract][Full Text] [Related]
15. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.
Qu Q; Sharom FJ
Biochemistry; 2002 Apr; 41(14):4744-52. PubMed ID: 11926837
[TBL] [Abstract][Full Text] [Related]
16. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis.
Eytan GD; Regev R; Assaraf YG
J Biol Chem; 1996 Feb; 271(6):3172-8. PubMed ID: 8621717
[TBL] [Abstract][Full Text] [Related]
17. Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter.
DiDiodato G; Sharom FJ
Biochem Pharmacol; 1997 Jun; 53(12):1789-97. PubMed ID: 9256153
[TBL] [Abstract][Full Text] [Related]
18. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
Assaraf YG; Borgnia MJ
Eur J Biochem; 1994 Jun; 222(3):813-24. PubMed ID: 7517866
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
[TBL] [Abstract][Full Text] [Related]
20. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
